{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:44:52Z","timestamp":1770338692336,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12094-012-0795-1","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T04:07:50Z","timestamp":1334549270000},"page":"271-279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma"],"prefix":"10.1007","volume":"14","author":[{"given":"Nourredine","family":"Himoudi","sequence":"first","affiliation":[]},{"given":"Rebecca","family":"Wallace","sequence":"additional","affiliation":[]},{"given":"Kathryn L.","family":"Parsley","sequence":"additional","affiliation":[]},{"given":"Kimberly","family":"Gilmour","sequence":"additional","affiliation":[]},{"given":"Alpha-Umaru","family":"Barrie","sequence":"additional","affiliation":[]},{"given":"Karen","family":"Howe","sequence":"additional","affiliation":[]},{"given":"Rong","family":"Dong","sequence":"additional","affiliation":[]},{"given":"Neil J.","family":"Sebire","sequence":"additional","affiliation":[]},{"given":"Antony","family":"Michalski","sequence":"additional","affiliation":[]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[]},{"given":"John","family":"Anderson","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,4,17]]},"reference":[{"key":"795_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nm0398-328","volume":"4","author":"F.O. Nestle","year":"1998","unstructured":"Nestle FO, Alijagic S, Gilliet M et al (1998) Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med 4: 328\u2013332","journal-title":"Nat Med"},{"key":"795_CR2","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","volume":"190","author":"B. Thurner","year":"1999","unstructured":"Thurner B, Haendle I, Roder C et al (1999) Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med 190:1669\u20131678","journal-title":"J Exp Med"},{"key":"795_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eururo.2006.03.061","volume":"50","author":"A. Berntsen","year":"2006","unstructured":"Berntsen A, Geertsen PF, Svane IM (2006) Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. Eur Urol 50:34\u201343","journal-title":"Eur Urol"},{"key":"795_CR4","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1399-3046.2008.01066.x","volume":"13","author":"A. Suminoe","year":"2009","unstructured":"Suminoe A, Matsuzaki A, Hattori H et al (2009) Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors. Pediatr Transplant 13:746\u2013753","journal-title":"Pediatr Transplant"},{"key":"795_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1200\/JCO.2008.14.0095","volume":"26","author":"P.A. Meyers","year":"2008","unstructured":"Meyers PA, Schwartz CL, Krailo MD et al (2008) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children\u2019s Oncology Group. J Clin Oncol 26:633\u2013638","journal-title":"J Clin Oncol"},{"key":"795_CR6","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.2106\/JBJS.G.01619","volume":"90","author":"E. Palmerini","year":"2008","unstructured":"Palmerini E, Staals EL, Ferrari S et al (2008) Nonresectable multiple lung metastases of high-grade osteosarcoma of the humerus: stable after twelve years. A case report. J Bone Joint Surg Am 90:2240\u20132244","journal-title":"A case report. J Bone Joint Surg Am"},{"key":"795_CR7","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1158\/1078-0432.CCR-09-1254","volume":"15","author":"A. Ribas","year":"2009","unstructured":"Ribas A, Comin-Anduix B, Chmielowski B et al (2009) Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res 15:6267\u20136276","journal-title":"Clin Cancer Res"},{"key":"795_CR8","first-page":"8513","volume":"61","author":"J.D. Geiger","year":"2001","unstructured":"Geiger JD, Hutchinson RJ, Hohenkirk LF et al (2001) Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. Cancer Res 61:8513\u20138519","journal-title":"Cancer Res"},{"key":"795_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/14653240701589221","volume":"9","author":"A.M. Dohnal","year":"2007","unstructured":"Dohnal AM, Witt V, Hugel H et al (2007) Phase I study of tumor Ag-loaded IL-12 secreting semimature DC for the treatment of pediatric cancer. Cytotherapy 9:755\u2013770","journal-title":"Cytotherapy"},{"key":"795_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1215\/S1152851703000668","volume":"6","author":"D.A. Caruso","year":"2004","unstructured":"Caruso DA, Orme LM, Neale AM et al (2004) Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer. Neuro Oncol 6:236\u2013246","journal-title":"Neuro Oncol"},{"key":"795_CR11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/sj.gt.3301288","volume":"7","author":"M. Brown","year":"2000","unstructured":"Brown M, Zhang Y, Dermine S et al (2000) Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity. Gene Ther 7:1680\u20131689","journal-title":"Gene Ther"},{"key":"795_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(00)02762-8","volume":"356","author":"J. Geiger","year":"2000","unstructured":"Geiger J, Hutchinson R, Hohenkirk L et al (2000) Treatment of solid tumours in children with tumourlysate-pulsed dendritic cells. Lancet 356: 1163\u20131165","journal-title":"Lancet"},{"key":"795_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00043426-200203000-00012","volume":"24","author":"A. Matsuzaki","year":"2002","unstructured":"Matsuzaki A, Suminoe A, Hattori H et al (2002) Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma. J Pediatr Hematol Oncol 24:220\u2013223","journal-title":"J Pediatr Hematol Oncol"},{"key":"795_CR14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pbc.22319","volume":"54","author":"H. Ardon","year":"2010","unstructured":"Ardon H, De Vleeschouwer S, Van Calenbergh F et al (2010) Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Pediatr Blood Cancer 54:519\u2013525","journal-title":"Pediatr Blood Cancer"},{"key":"795_CR15","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1084\/jem.192.11.1535","volume":"192","author":"F. Berard","year":"2000","unstructured":"Berard F, Blanco P, Davoust J et al (2000) Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 192:1535\u20131544","journal-title":"J Exp Med"},{"key":"795_CR16","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/intimm\/dxh335","volume":"17","author":"M.T. Rubio","year":"2005","unstructured":"Rubio MT, Means TK, Chakraverty R et al (2005) Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs. Int Immunol 17:1561\u20131572","journal-title":"Int Immunol"},{"key":"795_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jpedsurg.2006.09.008","volume":"42","author":"J. Shilyansky","year":"2007","unstructured":"Shilyansky J, Jacobs P, Doffek K et al (2007) Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor. J Pediatr Surg 42:54\u201361; discussion 61","journal-title":"J Pediatr Surg"},{"key":"795_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","volume":"23","author":"S.G. Harris","year":"2002","unstructured":"Harris SG, Padilla J, Koumas L et al (2002) Prostaglandins as modulators of immunity. Trends Immunol 23:144\u2013150","journal-title":"Trends Immunol"},{"key":"795_CR19","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1182\/blood-2008-05-155408","volume":"112","author":"C. Chizzolini","year":"2008","unstructured":"Chizzolini C, Chicheportiche R, Alvarez M et al (2008) Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112:3696\u20133703","journal-title":"Blood"},{"key":"795_CR20","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/eji.200838969","volume":"39","author":"G. Napolitani","year":"2009","unstructured":"Napolitani G, Acosta-Rodriguez EV, Lanzavecchia A et al (2009) Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells. Eur J Immunol 39:1301\u20131312","journal-title":"Eur J Immunol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-012-0795-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0795-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T03:44:05Z","timestamp":1744170245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-012-0795-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0795-1","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"15 June 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}